These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38518269)

  • 1. Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.
    Tabaac BJ; Shinozuka K; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e121-e132. PubMed ID: 38518269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of serotonin 5-HT
    Ibi D
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.
    Tabaac BJ; Shinozuka K; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e97-e103. PubMed ID: 38518266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
    N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
    Raison CL; Sanacora G; Woolley J; Heinzerling K; Dunlop BW; Brown RT; Kakar R; Hassman M; Trivedi RP; Robison R; Gukasyan N; Nayak SM; Hu X; O'Donnell KC; Kelmendi B; Sloshower J; Penn AD; Bradley E; Kelly DF; Mletzko T; Nicholas CR; Hutson PR; Tarpley G; Utzinger M; Lenoch K; Warchol K; Gapasin T; Davis MC; Nelson-Douthit C; Wilson S; Brown C; Linton W; Ross S; Griffiths RR
    JAMA; 2023 Sep; 330(9):843-853. PubMed ID: 37651119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Up-to-Date on clinical and preclinical studies of psilocybin therapy].
    Ibi D
    Nihon Yakurigaku Zasshi; 2024; 159(4):214-218. PubMed ID: 38945903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.
    Agrawal M; Richards W; Beaussant Y; Shnayder S; Ameli R; Roddy K; Stevens N; Richards B; Schor N; Honstein H; Jenkins B; Bates M; Thambi P
    Cancer; 2024 Apr; 130(7):1137-1146. PubMed ID: 38105655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
    Rosenblat JD; Husain MI; Lee Y; McIntyre RS; Mansur RB; Castle D; Offman H; Parikh SV; Frey BN; Schaffer A; Greenway KT; Garel N; Beaulieu S; Kennedy SH; Lam RW; Milev R; Ravindran AV; Tourjman V; Ameringen MV; Yatham LN; Taylor V
    Can J Psychiatry; 2023 Jan; 68(1):5-21. PubMed ID: 35975555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of psilocybin drugs in the treatment of depression.
    Śladowska K; Kawalec P; Brzostek T; Pilc A
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):241-256. PubMed ID: 37817501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of psilocybin for treatment-resistant depression].
    Johannesdottir A; Sigurdsson E
    Laeknabladid; 2022 Sep; 108(9):403-410. PubMed ID: 36040772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
    Goodwin GM; Croal M; Feifel D; Kelly JR; Marwood L; Mistry S; O'Keane V; Peck SK; Simmons H; Sisa C; Stansfield SC; Tsai J; Williams S; Malievskaia E
    Neuropsychopharmacology; 2023 Sep; 48(10):1492-1499. PubMed ID: 37443386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.
    Rosenblat JD; Meshkat S; Doyle Z; Kaczmarek E; Brudner RM; Kratiuk K; Mansur RB; Schulz-Quach C; Sethi R; Abate A; Ali S; Bawks J; Blainey MG; Brietzke E; Cronin V; Danilewitz J; Dhawan S; Di Fonzo A; Di Fonzo M; Drzadzewski P; Dunlop W; Fiszter H; Gomes FA; Grewal S; Leon-Carlyle M; McCallum M; Mofidi N; Offman H; Riva-Cambrin J; Schmidt J; Smolkin M; Quinn JM; Zumrova A; Marlborough M; McIntyre RS
    Med; 2024 Mar; 5(3):190-200.e5. PubMed ID: 38359838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
    Gukasyan N; Davis AK; Barrett FS; Cosimano MP; Sepeda ND; Johnson MW; Griffiths RR
    J Psychopharmacol; 2022 Feb; 36(2):151-158. PubMed ID: 35166158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
    Goodwin GM; Aaronson ST; Alvarez O; Arden PC; Baker A; Bennett JC; Bird C; Blom RE; Brennan C; Brusch D; Burke L; Campbell-Coker K; Carhart-Harris R; Cattell J; Daniel A; DeBattista C; Dunlop BW; Eisen K; Feifel D; Forbes M; Haumann HM; Hellerstein DJ; Hoppe AI; Husain MI; Jelen LA; Kamphuis J; Kawasaki J; Kelly JR; Key RE; Kishon R; Knatz Peck S; Knight G; Koolen MHB; Lean M; Licht RW; Maples-Keller JL; Mars J; Marwood L; McElhiney MC; Miller TL; Mirow A; Mistry S; Mletzko-Crowe T; Modlin LN; Nielsen RE; Nielson EM; Offerhaus SR; O'Keane V; Páleníček T; Printz D; Rademaker MC; van Reemst A; Reinholdt F; Repantis D; Rucker J; Rudow S; Ruffell S; Rush AJ; Schoevers RA; Seynaeve M; Shao S; Soares JC; Somers M; Stansfield SC; Sterling D; Strockis A; Tsai J; Visser L; Wahba M; Williams S; Young AH; Ywema P; Zisook S; Malievskaia E
    N Engl J Med; 2022 Nov; 387(18):1637-1648. PubMed ID: 36322843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.
    Ledwos N; Rosenblat JD; Blumberger DM; Castle DJ; McIntyre RS; Mulsant BH; Husain MI
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):581-588. PubMed ID: 36193898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT
    Sekssaoui M; Bockaert J; Marin P; Bécamel C
    Neuropsychopharmacology; 2024 Mar; 49(4):747-756. PubMed ID: 38212441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.
    Ling S; Ceban F; Lui LMW; Lee Y; Teopiz KM; Rodrigues NB; Lipsitz O; Gill H; Subramaniapillai M; Mansur RB; Lin K; Ho R; Rosenblat JD; Castle D; McIntyre RS
    CNS Drugs; 2022 Jan; 36(1):17-30. PubMed ID: 34791625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.
    Erritzoe D; Barba T; Spriggs MJ; Rosas FE; Nutt DJ; Carhart-Harris R
    J Psychopharmacol; 2024 May; 38(5):458-470. PubMed ID: 38520045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.